SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.460-3.1%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Winkler who wrote (848)1/8/1999 10:08:00 PM
From: Anthony Wong  Read Replies (1) of 2539
 
ADVISORY/Kaiser Permanente in California has Made No Decision On
Celebrex

--(BW HealthWire)--

A New York Times story Friday speculates that Kaiser Permanente's California Division is considering not covering the newly approved arthritis drug Celebrex.

This is only the newspaper's speculation, not a reflection of Kaiser Permanente's position. The Food and Drug Administration only last week approved the drug, noted Media Relations Director Tom Debley. The process of formulary review is just beginning. At least two physician formulary committees, one in Southern California and one in Northern California, must review a new drug before decisions can be made on a statewide basis. No decision has been made. ''To speculate on the outcome only a few days into a complex, perhaps months-long process, is pure conjecture,'' Debley said.

News organizations considering reporting the New York Times' conclusion should read the entire story. There is no statement from Kaiser Permanente's physician to support the story's conjecture that ''Kaiser Permanente of California is considering not covering Celebrex at all.''

Contact:

Kaiser Permanente News Bureau
Tom Debley, Lila Petersen or Ann Mosher, 510/987-3900
biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News